» Articles » PMID: 33580145

Mechanism of Karyopherin-β2 Binding and Nuclear Import of ALS Variants FUS(P525L) and FUS(R495X)

Overview
Journal Sci Rep
Specialty Science
Date 2021 Feb 13
PMID 33580145
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the RNA-binding protein FUS cause familial amyotropic lateral sclerosis (ALS). Several mutations that affect the proline-tyrosine nuclear localization signal (PY-NLS) of FUS cause severe juvenile ALS. FUS also undergoes liquid-liquid phase separation (LLPS) to accumulate in stress granules when cells are stressed. In unstressed cells, wild type FUS resides predominantly in the nucleus as it is imported by the importin Karyopherin-β2 (Kapβ2), which binds with high affinity to the C-terminal PY-NLS of FUS. Here, we analyze the interactions between two ALS-related variants FUS(P525L) and FUS(R495X) with importins, especially Kapβ2, since they are still partially localized to the nucleus despite their defective/missing PY-NLSs. The crystal structure of the Kapβ2·FUS(P525L) complex shows the mutant peptide making fewer contacts at the mutation site, explaining decreased affinity for Kapβ2. Biochemical analysis revealed that the truncated FUS(R495X) protein, although missing the PY-NLS, can still bind Kapβ2 and suppresses LLPS. FUS(R495X) uses its C-terminal tandem arginine-glycine-glycine regions, RGG2 and RGG3, to bind the PY-NLS binding site of Kapβ2 for nuclear localization in cells when arginine methylation is inhibited. These findings suggest the importance of the C-terminal RGG regions in nuclear import and LLPS regulation of ALS variants of FUS that carry defective PY-NLSs.

Citing Articles

NLS-binding deficient Kapβ2 reduces neurotoxicity via selective interaction with C9orf72-ALS/FTD dipeptide repeats.

Kim K, Girdhar A, Cicardi M, Kankate V, Hayashi M, Yang R Commun Biol. 2025; 8(1):2.

PMID: 39747573 PMC: 11696677. DOI: 10.1038/s42003-024-07412-x.


Engineered NLS-chimera downregulates expression of aggregation-prone endogenous FUS.

Hayashi M, Girdhar A, Ko Y, Kim K, DePierro J, Buchler J Nat Commun. 2024; 15(1):7887.

PMID: 39251571 PMC: 11384663. DOI: 10.1038/s41467-024-52151-6.


An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates liquid-solid phase transition.

Shiramasa Y, Yamamoto R, Kashiwagi N, Sasaki F, Imai S, Ike M Sci Rep. 2024; 14(1):8914.

PMID: 38632300 PMC: 11024109. DOI: 10.1038/s41598-024-59604-4.


Phosphorylation, disorder, and phase separation govern the behavior of Frequency in the fungal circadian clock.

Tariq D, Maurici N, Bartholomai B, Chandrasekaran S, Dunlap J, Bah A Elife. 2024; 12.

PMID: 38526948 PMC: 10963029. DOI: 10.7554/eLife.90259.


Nuclear pore dysfunction and disease: a complex opportunity.

Fare C, Rothstein J Nucleus. 2024; 15(1):2314297.

PMID: 38383349 PMC: 10883112. DOI: 10.1080/19491034.2024.2314297.


References
1.
Andersen P, Al-Chalabi A . Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat Rev Neurol. 2011; 7(11):603-15. DOI: 10.1038/nrneurol.2011.150. View

2.
Harrison A, Shorter J . RNA-binding proteins with prion-like domains in health and disease. Biochem J. 2017; 474(8):1417-1438. PMC: 5639257. DOI: 10.1042/BCJ20160499. View

3.
Sama R, Ward C, Bosco D . Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro. 2014; 6(4). PMC: 4189536. DOI: 10.1177/1759091414544472. View

4.
Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T . The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol. 2005; 15(6):587-93. DOI: 10.1016/j.cub.2005.01.058. View

5.
Schoen M, Reichel J, Demestre M, Putz S, Deshpande D, Proepper C . Super-Resolution Microscopy Reveals Presynaptic Localization of the ALS/FTD Related Protein FUS in Hippocampal Neurons. Front Cell Neurosci. 2016; 9:496. PMC: 4709451. DOI: 10.3389/fncel.2015.00496. View